novo nordisk's semaglutide failed to slow alzheimer's disease progression AD/PD 2026: fails demonstrate any benefit for early Novo Nordisk's semaglutide misses in

Astrocytes, as the primary lactate producers via aerobic glycolysis, maintain a high glycolytic flux (Zhou et al., 2024

Its like anything, I do it in moderation. Dr Patrick Bowler, a Harley Street dermatologist, told Channel 4 News that vanity is powerful force, which means even people afraid of needle overcome their fears

FDA Commissioner Marty Makary, M.D., publicly pledged to take swift action against companies that mass-market what he characterized as illegal copycat drugs. While Hims & Hers ultimately retreated from its plans in the face of mounting legal pressure, the episode served as a watershed moment, putting the industry on notice that the FDA intended to draw a firm line between legitimate compounding and unauthorized mass-market drug distribution

JAMA Surg